<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20250823066963N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-10-12</date_registration>
      <primary_sponsor>Kerman University of Medical Sciences</primary_sponsor>
      <public_title>Effect of Oral Mucosa Stem Cells on Healing and Shoulder Function in Patients with Rotator Cuff Muscle Tear</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the Effect of Oral Mucosa Stem Cell Therapy and Standard Surgical Repair on Pain Relief, Healing, and Shoulder Function in Patients with Rotator Cuff Muscle Tear: A Randomized Clinical Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-10-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>20</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/86734</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In this study, eligible patients were randomly assigned to either the intervention group (oral mucosa stem cell therapy combined with standard surgical repair) or the control group (standard surgical repair only) after initial assessment and obtaining written informed consent.
Randomization was simple randomization, and the unit of randomization was individual. The random sequence was generated using a random number table in SPSS version 26 by an independent researcher who was not involved in the intervention or outcome assessment.
To ensure allocation concealment, the randomization codes were sealed in opaque, sequentially numbered envelopes. Each envelope was opened only at the time of participant enrollment, ensuring that neither the surgeon nor the outcome assessor was aware of the allocation beforehand, Blinding description: A double-blind design was applied in this trial.
Participants were unaware of their group assignment (whether they received stem cell injection or not). All patients underwent the same surgical procedure with identical incisions to prevent awareness of treatment differences.
Stem cell sampling and preparation of the suspension were performed by an independent laboratory team, separate from the surgical staff. The injection (stem cell suspension or normal saline) was administered by the same surgeon, who was blinded to the content of each coded syringe prepared by the independent team.
Nurses and physiotherapists responsible for postoperative care were not informed about group allocation.
The evaluator of shoulder function and the data analyst were also blinded to the intervention type to minimize measurement and interpretation bias.
Randomization codes were opened only after completion of data collection by the principal investigator.</study_design>
      <phase>2</phase>
      <hc_freetext>Rotator cuff tear of shoulder.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:  Patients in this group receive oral mucosa–derived mesenchymal stem cell therapy combined with standard surgical repair of the rotator cuff tendon.Initially, a small biopsy (approximately 3×3 millimeters) is obtained from the oral mucosa under local anesthesia. Mesenchymal stem cells are isolated and expanded in a specific culture medium under sterile conditions. During surgical repair, a cell suspension containing approximately one million cells in one milliliter of normal saline is injected at the tendon–bone interface. This procedure is performed during the same surgical session. After surgery, patients are followed according to the standard rehabilitation protocol. Intervention 2: Control group:Patients in this group undergo standard surgical repair of the rotator cuff tendon without any stem cell or additional injection.The surgical procedure involves open or arthroscopic repair of the torn tendon using nonabsorbable sutures at the tendon–bone junction. All surgeries are performed by the same surgeon, and postoperative care and rehabilitation protocols are identical in both groups.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No further information is available</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Ali Torabi nejad kermani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.6,2 Sharghi,2 Zafar Street,Kerman Town</address>
        <city>Kerman</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7613747181</zip>
        <telephone>+98 34 3244 5959</telephone>
        <email>Alitorabinejad99@gmail.com</email>
        <affiliation>Kerman University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Amirreza Sadeghi Far</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Gharani Street, Shahid Bahonar Hospital</address>
        <city>Kerman</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7613747181</zip>
        <telephone>+98 34 3223 5011</telephone>
        <email>bahonarh@kmu.ac.ir</email>
        <affiliation>Kerman University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age over 18 years
Written informed consent to participate in the study
Full-thickness tear of the supraspinatus tendon
Retraction less than 30 mm on MRI
No fatty degeneration in the rotator cuff muscle
Shoulder pain or weakness for at least 3 months without improvement with non-surgical treatment</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Pregnancy
Shoulder osteoarthritis
Previous shoulder surgery or fracture
Psychiatric disorders or fibromyalgia
Painful cervical spine pathology
Rheumatic diseases
Chronic corticosteroid or NSAID use
Coagulation disorders or thrombocytopenia
Vascular or neurological shoulder lesions
Severe uncontrolled comorbid diseases</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M75.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Rotator cuff tear or rupture, not specified as traumatic</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:  Patients in this group receive oral mucosa–derived mesenchymal stem cell therapy combined with standard surgical repair of the rotator cuff tendon.Initially, a small biopsy (approximately 3×3 millimeters) is obtained from the oral mucosa under local anesthesia. Mesenchymal stem cells are isolated and expanded in a specific culture medium under sterile conditions. During surgical repair, a cell suspension containing approximately one million cells in one milliliter of normal saline is injected at the tendon–bone interface. This procedure is performed during the same surgical session. After surgery, patients are followed according to the standard rehabilitation protocol.</i_keyword>
      <i_keyword>Control group:Patients in this group undergo standard surgical repair of the rotator cuff tendon without any stem cell or additional injection.The surgical procedure involves open or arthroscopic repair of the torn tendon using nonabsorbable sutures at the tendon–bone junction. All surgeries are performed by the same surgeon, and postoperative care and rehabilitation protocols are identical in both groups.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Shoulder pain intensity based on the Visual Analogue Scale. Timepoint: At baseline (before intervention) and at one, two, and three months after surgery. Method of measurement: Pain intensity is measured using a ten-centimeter Visual Analogue Scale where zero indicates no pain and ten indicates the worst imaginable pain.</prim_outcome>
      <prim_outcome>Shoulder joint range of motion in flexion, extension, abduction, and external rotation. Timepoint: At baseline and three months after surgery. Method of measurement: Range of motion is measured using a goniometer by a trained physiotherapist in standardized positions.</prim_outcome>
      <prim_outcome>Tendon healing status in follow-up imaging. Timepoint: Three months after surgery. Method of measurement: Tendon healing is evaluated using magnetic resonance imaging (MRI) interpreted by an independent radiologist.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Kerman University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-08-12</approval_date>
        <contact_name>Ethics committee of Kerman University of Medical Sciences</contact_name>
        <contact_address>Beginning of Haft Bagh Alavi Blvd., Kerman University of Medical Sciences Campus Kerman Kerman Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
